(Q37974614)

26 August 2017

title

Molecular classification of breast carcinomas with particular emphasis on "basal-like" carcinoma: a critical review (English)

1 reference

26 August 2017

author name string

Mohammad Ali Lavasani

series ordinal

1

1 reference

26 August 2017

Farid Moinfar

series ordinal

2

1 reference

26 August 2017

publication date

9 January 2012

1 reference

26 August 2017

published in

Journal of Biophotonics

1 reference

26 August 2017

volume

5

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

345-366

1 reference

An overview of prognostic factors for long-term survivors of breast cancer

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

21 January 2018

TP53 and breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

p53 and breast cancer, an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Light-generated oligonucleotide arrays for rapid DNA sequence analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Limits of predictive models using microarray data for breast cancer clinical treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Current issues for DNA microarrays: platform comparison, double linear amplification, and universal RNA reference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Replication validity of genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Outcome signature genes in breast cancer: is there a unique set?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Genomics in breast cancer-therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Gene-expression analysis and the basal-like breast cancer subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Deconstructing the molecular portraits of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

The phenotypic spectrum of basal-like breast cancers: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Metaplastic breast carcinomas are basal-like tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Metaplastic carcinoma of the breast: a clinicopathological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Prognostic relevance of basal cytokeratin expression in operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Do 'basal-like' breast cancers really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Basal-like breast cancer and the BRCA1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Differences in risk factors for breast cancer molecular subtypes in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Basal-like breast carcinomas: clinical outcome and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Treatment of triple negative breast cancer (TNBC): current options and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Is molecular profiling ready for use in clinical decision making?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Histological and molecular types of breast cancer: is there a unifying taxonomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBIO.201100097

21 January 2018

Identifiers

DOI

10.1002/JBIO.201100097

1 reference

26 August 2017

1 reference